OMX Copenhagen 20
1.811,66
PKT
+2,35
PKT
+0,13
%
Werbung
Analysen zu OMX Copenhagen 20-Werten
Datum | Rating | Analyst | |
---|---|---|---|
07.04.20 | Novo Nordisk Hold | Deutsche Bank AG | |
07.04.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
06.04.20 | Novo Nordisk Hold | Deutsche Bank AG | |
31.03.20 | Novo Nordisk Neutral | Oddo BHF | |
27.03.20 | A.P. Moeller - Maersk A-S (B) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
27.03.20 | A.P. Moeller - Maersk A-S (B) Neutral | JP Morgan Chase & Co. | |
24.03.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
23.03.20 | Novo Nordisk buy | UBS AG | |
18.03.20 | Novo Nordisk Outperform | Bernstein Research | |
17.03.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
17.03.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
17.03.20 | Novo Nordisk overweight | Barclays Capital | |
06.03.20 | A.P. Moeller - Maersk A-S (B) kaufen | Jefferies & Company Inc. | |
05.03.20 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
02.03.20 | Novo Nordisk overweight | Barclays Capital | |
25.02.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
25.02.20 | A.P. Moeller - Maersk A-S (B) verkaufen | JP Morgan Chase & Co. | |
21.02.20 | A.P. Moeller - Maersk A-S (B) Hold | Deutsche Bank AG | |
20.02.20 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
11.02.20 | Novo Nordisk Hold | Deutsche Bank AG | |
06.02.20 | Novo Nordisk Outperform | Credit Suisse Group | |
06.02.20 | Novo Nordisk Neutral | UBS AG | |
06.02.20 | Novo Nordisk overweight | Barclays Capital | |
06.02.20 | Novo Nordisk Outperform | Bernstein Research | |
06.02.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.02.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
06.02.20 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
05.02.20 | Novo Nordisk overweight | Barclays Capital | |
05.02.20 | Novo Nordisk Outperform | Bernstein Research | |
05.02.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
05.02.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
31.01.20 | Novo Nordisk overweight | Barclays Capital | |
29.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
27.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
22.01.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
20.01.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
17.01.20 | Novo Nordisk overweight | Barclays Capital | |
17.01.20 | Novo Nordisk Neutral | UBS AG | |
17.01.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
16.01.20 | Novo Nordisk overweight | Barclays Capital |